GeneDx Holdings Corp. has announced the appointment of Dr. Mimi Lee, MD, PhD, as Chief Precision Medicine Officer. Dr. Lee will lead the company's initiatives to advance precision medicine and integrate genomics into healthcare to improve health outcomes. She joins GeneDx from the Advanced Research Projects Agency for Health (ARPA-H) and brings experience from roles in academia, biotechnology, and the biopharmaceutical industry.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251014928013) on October 14, 2025, and is solely responsible for the information contained therein.